Karin Seron,Jean Dubuisson,Yves Rouille,Czeslaw Wychowski
申请号：
US14008031
公开号：
US20140088184A1
申请日:
2012.03.28
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to a flavonoid compound having the formula I, where R3, R5 and/or R7 is a group having the formula II, or R1 and R2 are both OH groups, or to one of the pharmaceutically acceptable salts or esters thereof, for use as an antiviral agent in the treatment and/or prevention of a hepatitis C virus (HCV) infection. The invention also relates to an ex vivo method for reducing the infectivity of HCV or for inactivating HCV, including a step of contacting said hepatitis C virus with a compound having the formula (I).
